Zymo Research and Hamilton Robotics Partner to Automate Epigenetics Research

Published by , March 27, 2017 10:51 am

(BioSpace)  Zymo Research Corp., also known as ‘the epigenetics company’, and Hamilton Robotics, Inc., who designs, manufactures and distributes liquid handling workstations, announced an ongoing collaboration that teams Zymo Research’s DNA methylation detection and quantitation products and RNA and DNA extraction products with Hamilton’s high-throughput automation platforms.
Epigenetics may hold important keys to unlocking a myriad of diseases and disorders, such as cancer, autism, Alzheimer’s, and addictions. The global epigenetics market is expected to reach $1,286 million by 2022 growing at a Compound Annual Growth Rate (CAGR) of 14.4% from 2015 to 2022*. According to Marc Van Eden, Vice President of Business Development at Zymo Research, “Understanding the role of epigenetic mechanisms in the regulation of gene expression is an emerging field. By combining Zymo Research’s epigenetics expertise with Hamilton Robotics automated systems, researchers are able to automate routine, mundane tasks leading to fewer errors and more efficient workflows.”

Tags: , , ,